Sanofi (EPA:SAN)
76.39
-1.34 (-1.72%)
At close: Mar 6, 2026
Sanofi Revenue
In the year 2025, Sanofi had annual revenue of 46.72B EUR with 5.49% growth. Sanofi had revenue of 12.21B in the quarter ending December 31, 2025.
Revenue
46.72B
Revenue Growth
+5.49%
P/S Ratio
1.97
Revenue / Employee
624.16K
Employees
74,846
Market Cap
92.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 46.72B | 2.43B | 5.49% |
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Eurofins Scientific SE | 7.30B |
| bioMérieux | 4.07B |
| ABIVAX Société Anonyme | 5.31M |
| Virbac | 1.43B |
| emeis Société anonyme | 5.77B |
Sanofi News
- 1 day ago - Sanofi (SNY) to Sell Medley to EMS in $500M+ Deal - GuruFocus
- 1 day ago - EMA Panel Backs Moderna's COVID-Flu Shot, Sanofi's Sleeping Sickness Drug, Ipsen's Cancer Drug - Nasdaq
- 1 day ago - Need Growing EPS And Dividends? Prescribe Sanofi - Seeking Alpha
- 3 days ago - Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director - GlobeNewsWire
- 3 days ago - Press Release: Filing of an amendment to the French "Document d'Enregistrement Universel" containing the Annual Financial Report - Benzinga
- 3 days ago - Press Release: Filing of an amendment to the French “Document d'Enregistrement Universel” containing the Annual Financial Report - GlobeNewsWire
- 3 days ago - Sino Biopharmaceutical (SBHMY) Strikes $1.53B Deal with Sanofi for Cancer Drug - GuruFocus
- 4 days ago - Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters